{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T08:43:45Z","timestamp":1777884225227,"version":"3.51.4"},"reference-count":11,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100019579","name":"SingHealth","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019579","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007419","name":"Lee Foundation","doi-asserted-by":"publisher","award":["SDTC\/LFG\/2024\/001"],"award-info":[{"award-number":["SDTC\/LFG\/2024\/001"]}],"id":[{"id":"10.13039\/100007419","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplant Immunology"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.trim.2026.102344","type":"journal-article","created":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T16:09:47Z","timestamp":1767974987000},"page":"102344","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Recovery of CMV immunity after allogeneic haematopoietic stem cell transplant \u2014 Insight from an in-depth analysis of a small cohort of patients with clinical correlation"],"prefix":"10.1016","volume":"94","author":[{"given":"Yeh-ching","family":"Linn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kirubavathy","family":"Sundar Raj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.trim.2026.102344_bb0005","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1093\/cid\/ciz1210","article-title":"Cytomegalovirus (CMV) cell-mediated immunity and CMV infection after allogeneic hematopoietic cell transplantation: the REACT study","volume":"71","author":"Chemaly","year":"2020","journal-title":"Clin. Infect. Dis."},{"issue":"8","key":"10.1016\/j.trim.2026.102344_bb0010","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofad386","article-title":"Impact of baseline and week 2 and week 4 posttransplant CMV cell-mediated immunity on risk of CMV infections and mortality in recipients of allogeneic hematopoietic cell transplant","volume":"10","author":"Ariza-Heredia","year":"2023","journal-title":"Open Forum Infect. Dis."},{"issue":"2","key":"10.1016\/j.trim.2026.102344_bb0015","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.jim.2003.12.007","article-title":"CD28 costimulation enhances the sensitivity of the ELISPOT assay for detection of antigen-specific memory effector CD4 and CD8 cell populations in human diseases","volume":"285","author":"Ott","year":"2004","journal-title":"J. Immunol. Methods"},{"issue":"11","key":"10.1016\/j.trim.2026.102344_bb0020","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1093\/infdis\/jiw064","article-title":"Utility of the enzyme-linked immunospot interferon-\u03b3\u2013release assay to predict the risk of cytomegalovirus infection in hematopoietic cell transplant recipients","volume":"213","author":"Nesher","year":"2016","journal-title":"J. Infect. Dis."},{"issue":"6","key":"10.1016\/j.trim.2026.102344_bb0025","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1093\/infdis\/jiy592","article-title":"The ability of a cytomegalovirus ELISPOT assay to predict outcome of low-level CMV reactivation in hematopoietic cell transplant recipients","volume":"219","author":"Haddad","year":"2018","journal-title":"J. Infect. Dis."},{"issue":"3","key":"10.1016\/j.trim.2026.102344_bb0030","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1093\/cid\/ciae321","article-title":"Consensus definitions of cytomegalovirus (CMV) infection and disease in transplant patients including resistant and refractory CMV for use in clinical trials: 2024 update from the transplant associated virus infections forum","volume":"79","author":"Ljungman","year":"2024","journal-title":"Clin. Infect. Dis."},{"issue":"11","key":"10.1016\/j.trim.2026.102344_bb0035","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1016\/j.bbmt.2020.07.024","article-title":"Low-level cytomegalovirus antigenemia promotes protective cytomegalovirus antigen-specific T cells after allogeneic hematopoietic cell transplantation","volume":"26","author":"Chen","year":"2020","journal-title":"Biol. Blood Marrow Transplant."},{"issue":"10","key":"10.1016\/j.trim.2026.102344_bb0040","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1016\/j.bbmt.2018.05.001","article-title":"Deleterious effect of steroids on cytomegalovirus infection rate after allogeneic stem cell transplantation depends on pretransplant cytomegalovirus serostatus of donors and recipients","volume":"24","author":"Su\u00e1rez-Lled\u00f3","year":"2018","journal-title":"Biol. Blood Marrow Transplant."},{"issue":"1","key":"10.1016\/j.trim.2026.102344_bb0045","doi-asserted-by":"crossref","DOI":"10.1186\/s12985-024-02421-y","article-title":"Characterization of recurrent cytomegalovirus reactivations post allogenic stem cell transplantation in a population with high seropositivity","volume":"21","author":"AlQahtani","year":"2024","journal-title":"Virol. J."},{"issue":"2","key":"10.1016\/j.trim.2026.102344_bb0050","doi-asserted-by":"crossref","first-page":"363","DOI":"10.3324\/haematol.2019.229252","article-title":"Standardized monitoring of cytomegalovirus-specific immunity can improve risk stratification of recurrent cytomegalovirus reactivation after hematopoietic stem cell transplantation","volume":"106","author":"Wagner-Drouet","year":"2019","journal-title":"Haematologica"},{"issue":"8","key":"10.1016\/j.trim.2026.102344_bb0055","doi-asserted-by":"crossref","first-page":"e451","DOI":"10.1016\/S1473-3099(25)00069-6","article-title":"Recommendations from the 10th European conference on infections in leukaemia for the management of cytomegalovirus in patients after allogeneic haematopoietic cell transplantation and other T-cell-engaging therapies","volume":"25","author":"Ljungman","year":"2025","journal-title":"Lancet Infect. Dis."}],"container-title":["Transplant Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0966327426000018?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0966327426000018?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T02:17:24Z","timestamp":1777601844000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0966327426000018"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":11,"alternative-id":["S0966327426000018"],"URL":"https:\/\/doi.org\/10.1016\/j.trim.2026.102344","relation":{},"ISSN":["0966-3274"],"issn-type":[{"value":"0966-3274","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recovery of CMV immunity after allogeneic haematopoietic stem cell transplant \u2014 Insight from an in-depth analysis of a small cohort of patients with clinical correlation","name":"articletitle","label":"Article Title"},{"value":"Transplant Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.trim.2026.102344","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102344"}}